Investigation of the feasibility of manufacturing a spray-dried formulation of the synthetic peptide, AP301 Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014
Novel omalizumab liquid formulation bioequivalent to lyophilized formulation Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
Quantitation method for colistimethate sodium in pharmaceutical aerosol samples using high performance liquid chromatography (HPLC) Source: International Congress 2016 – Airway biomarkers Year: 2016
EPITOME-2: Evaluation of a new formulation of epoprostenol sodium in pulmonary arterial hypertension patients switched from an originally approved formulation Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
Bioequivalence of a new formulation of omalizumab, solution for injection in prefilled syringe, to the current lyophilized formulation Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Pharmacoeconomic aspects of drug susceptibility testing of M. tuberculosis using automated liquid culture systems and solid media Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology Source: Annual Congress 2009 - Respiratory disorders of the newborn Year: 2009
Improvement of pulmonary drug delivery by eFlow™, a novel electronic inhaler making use of a vibrating membrane principle Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003
Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group) Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Development of a powder for inhalation with R,R-Glycopyrrolate as active ingredient for the delivery from a novel multidose dry powder inhaler Source: Eur Respir J 2003; 22: Suppl. 45, 471s Year: 2003
Effects of nebulizer treatment with peptide-containing formulation on bronchial passage in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002
Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function Source: Annual Congress 2010 - COPD: management Year: 2010
Medical nanoparticles for next generation drug delivery to the lungs Source: Eur Respir J 2014; 44: 765-774 Year: 2014
Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation Source: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
EPITOME-4, a phase 3b study evaluating a new formulation of epoprostenol sodium in pulmonary arterial hypertension following switch from Flolan® Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Macro and microscopic evaluation of paclitaxel delivery in the airway with a novel endobronchial injectable drug delivery catheter Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more Year: 2013
Effect of device and formulation on delivery of budesonide suspensions by nebulizers Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
The contribution of quantitative determinations through HPLC (high performance liquid chromatography), of the antituberculosis drugs in serum, in prevention of relapses Source: Eur Respir J 2004; 24: Suppl. 48, 645s Year: 2004
A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser Source: Eur Respir J 2003; 22: Suppl. 45, 471s Year: 2003
Assessment of lung deposition and pharmacokinetics in 12 lung transplanted patients after inhalation of a novel liposomal ciclosporin a (CsA) formulation by the eFlow electronic nebuliser Source: Eur Respir J 2007; 30: Suppl. 51, 29s Year: 2007